Author:
Wang Xiaohua,Zhang Jintao,Baylink David J.,Li Chih-Huang,Watts Douglas M.,Xu Yi,Qin Xuezhong,Walter Michael H.,Tang Xiaolei
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Melcon, M. O., Correale, J. & Melcon, C. M. Is it time for a new global classification of multiple sclerosis? Journal of the neurological sciences 344, 171, doi: 10.1016/j.jns (2014).
2. Ben-Nun, A. et al. From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development. J Autoimmun, doi: 10.1016/j.jaut (2014).
3. Clifford, D. B. et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. The Lancet. Neurology 9, 438, doi: 10.1016/S1474-4422(10)70028-4 (2010).
4. Linda, H. et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. The New England journal of medicine 361, 1081, doi: 10.1056/NEJM (2009).
5. Steinman, L. The re-emergence of antigen-specific tolerance as a potential therapy for MS. Mult Scler 21, 1223, doi: 10.1177/13524585155814411352458515581441 (2015).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献